China has the world’s largest iron deficiency anemia population with estimated prevalence of 15%1 Approval may also benefit the Chinese healthcare system, among others through implementation of a more
Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients Therapy recen
All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead the bu
Iron Deficiency Day unites a strong international coalition raising awareness on the serious health impact of iron deficiency and iron deficiency anemia1 This year, the focus is on importance of earl
/newsonfloor/media/post_banners/lfDHb9AXWWi2f9eRgOvg.jpg)
/newsonfloor/media/post_banners/GctJhFFBVk27md2b8hAD.jpg)
/newsonfloor/media/post_banners/rHgTnGXsBf9pULkVgijv.jpg)
/newsonfloor/media/post_banners/YazX5WlKH9Bf2jZZzQF7.jpg)
/newsonfloor/media/post_banners/Bwj3X4fq4zU8UJb0ZKqW.jpg)
/newsonfloor/media/post_banners/S4e5apPK61Dkt8HXgDdk.jpg)
